Cardiff Oncology (CRDF) Amortization of Deferred Charges (2024 - 2025)
Cardiff Oncology (CRDF) posted Amortization of Deferred Charges of $135000.0 for Q4 2025, little changed sequentially from $135000.0 in Q3 2025, and little changed YoY from $135000.0 in Q4 2024.
Cardiff Oncology (CRDF) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Cardiff Oncology has reported Amortization of Deferred Charges for 2 years, with the latest figure at $135000.0 in Q4 2025.
- Quarterly Amortization of Deferred Charges changed 0.0% year-over-year to $135000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $540000.0 (changed 0.19% YoY) and the FY2025 annual result came in at $540000.0, changed 0.19% from the prior year.
- Amortization of Deferred Charges held at $135000.0 in Q4 2025 per CRDF's latest filing, from $135000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $135000.0 in Q2 2024 and troughed at $134000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 135,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | 135,000.00 |
| Sep 30, 2025 | 135,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | 135,000.00 |
| Sep 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 134,000.00 |
| Mar 31, 2024 | 134,000.00 |